3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Rectal Neoplasms
2
Colonic Neoplasms
2
Breast Neoplasms
2
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Melanoma
1
Lung Neoplasms
1
Esophageal Neoplasms
1
Colorectal Neoplasms
1
Cardiotoxicity
1
Carcinoma, Renal Cell
1
Carcinoma, Non-Small-Cell Lung
1
Breast Neoplasms, Male
1
Adenocarcinoma Of Esophagus
1
Interventions
Cytarabine
26
Daunorubicin
10
Mitoxantrone
8
Idarubicin
8
fludarabine phosphate
6
Etoposide
6
Busulfan
6
Methotrexate
5
Gemtuzumab
5
Filgrastim
5
Clofarabine
5
tipifarnib
4
alvocidib
4
Vorinostat
4
Tacrolimus
4
Peripheral Blood Stem Cell Transplantation
4
Decitabine
4
Antilymphocyte Serum
4
sargramostim
3
Observation
3
Mycophenolic Acid
3
Flow Cytometry
3
Cytogenetic Analysis
3
Cyclosporine
3
Cyclophosphamide
3
CPX-351
3
Bortezomib
3
Azacitidine
3
Whole-Body Irradiation
2
Stem Cell Transplantation
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Has results
×
Leukemia, Monocytic, Acute
×
Mass Spectrometry
×
Clear all
No trials found.